IridologyNet FAQs

 
Contents:

Early dementia could be detected with a simple eye test, similar to those used to test for high blood pressure and diabetes, US scientists believe.

Eye test 'could spot Alzheimer's'
image of an eye
The eyes can reveal warning signs of many diseases
Early dementia could be detected with a simple eye test, similar to those used to test for high blood pressure and diabetes, US scientists believe.

The test, developed by a team led by Dr Lee Goldstein, of Brigham and Women's Hospital, Boston, uses a non-invasive laser to study the lens of the eye.

It checks for deposits of beta-amyloid - the protein found in the brains of those with Alzheimer's disease.

The procedure has worked in a trial in mice, a conference in Spain heard.

During the trial, a brief pulse of infrared light into the eyes of four mice with Alzheimer's and four without accurately identified which had the condition.

Dr Goldstein and his team envisage the test could be used to detect the disease at its earliest stages as well as to track disease progression and monitor how people respond to Alzheimer's treatments.

Currently there is no simple test to make a diagnosis of dementia and it can only be confirmed with certainty by looking at someone's brain in a post-mortem examination.

The scientists believe the technology, known as quasi-elastic light scattering, may detect the very earliest stages of amyloid deposits in the lens, even when they appear completely clear to the naked eye.

Early detection window

The amyloid deposits appear as unusual cataracts. These are different from common, age-related cataracts.

Dr Goldstein told the International Conference on Alzheimer's Disease and Related Disorders in Madrid: "Amyloid in the lens can be detected using extremely sensitive, non-invasive optical techniques.

"This makes the lens an ideal window for early detection and disease monitoring in Alzheimer's."

The scientists acknowledge that much more work is needed before such a test could be available to use in patients.

Professor Clive Ballard, of The Alzheimer's Society, said: "This exciting study uses a new imaging technique which has enormous potential as a relatively inexpensive and non-invasive way to chart the growth of amyloid, the protein at the core of the plaques which develop in the brain in a person with dementia.

"But we are long way from eye scans being regularly used to diagnosis someone with dementia.

"More research is needed to show exactly how the amount of protein in the eye relates to development of dementia."

Website http://news.bbc.co.uk/2/hi/health/5198602.stm

Back to Top






How irises 'reveal personalities'

It may be possible to read a person's personality through their eyes, Swedish researchers have said.

They have detected patterns which show warm-heartedness and trust or neuroticism and impulsiveness.

The team from Orebro University read pits and lines in the irises of 428 people.

Experts said the study in Biological Psychology showed that at least some aspects of personality were determined by genetics.

You would not want to arrest somebody on the basis of their iris
Dr George Fieldman, psychologist

Close-up pictures were taken of the study participants' irises, and they also filled out a questionnaire about their personalities.

The researchers looked at crypts (pits) and contraction furrows (lines curving around the outer edge of the iris), which are formed when pupils dilate.

It was found that those with more crypts were likely to be tender, warm and trusting, while those with more furrows were more likely to be neurotic, impulsive and give in to cravings.

'Trajectories'

The researchers suggest that a neurodevelopmental gene called PAX6 could also play a major role.

It is known to help control the development of the iris in an embryo.

Previous research has also shown that a mutation of PAX6 is linked to impulsiveness and poor social skills.

The team, led by Dr Matt Larsson a behavioural scientist, said: "These findings support the notion that people with different iris configurations tend to develop along different trajectories in regards to personality.

"Differences in the iris can be used as a biomarker that reflects differences between people."

Dr George Fieldman, principal lecturer in psychology at Buckinghamshire Chilterns University College, said: "This is very interesting. It shows that some aspects of personality have a genetic base and to identify them in the eye in this fascinating way is significant.

"It is surprising that this is possible. But it seems that the old aphorism that 'the eyes are the window to the soul' has some genetic basis."

He said it opened up the possibility that security services could one day use the technique to analyse people.

Airports, including Heathrow, Manchester and Gatwick are already testing iris scanning to identify people - but are not to check personality traits.

But Dr Fieldman added: "Security services would have to use such technologies with some caution. You would not want to arrest somebody on the basis of their iris."




Back to Top


Cervical Cancer Vaccine
A vaccine that is claimed to prevent cancer is causing damage that is a precursor to cancer?

Naturopath and Iridologist Michael Blake, of Natures Cure Pty Ltd in Dandenong, Melbourne
(web site http://www.naturaltherapypages.com.au/therapist/6025) is very concerned at what he has seen in the irises of four girls recently and his conscience will not allow him to stay silent.

In the area of the iris that corresponds to the uterus, in three of the girls he saw tissue damage, and in the fourth he saw drug residue. In each of the four cases, on reporting back to the patient what he was observing, he was informed that the girl had recently received the cervical cancer vaccine. All were virgins.

Tissue damage in the uterus is what he sees in women who have had such things as abortions and prolapses, and can be a precursor to cancer. It can also cause infertility - as it can prevent the embryo from being able to hold on to the uterus wall. It also often results in lack of sensitivity with sexual intercourse, pain, discomfort and/or frequent discharges.

Note that it has already been observed that one of the ingredients in the vaccine, polysorbate 80, has been observed to cause infertility in mice. Add to that borax, which is used to kill ants, add neurotoxic immune system sensitiser aluminium hydroxyphosphate, and directly inject all of that and any viral material (which is not proven to be in a harmless form) past the very important natural lines of defence in the immune system, then what do you think we are asking for, trouble or protection? I can't tell you what to do - you must figure it out for yourself.

Note also that the primary owners of the main pharmaceutical companies, including the manufacturer of this vaccine, are the extremely wealthy and powerful Rockefeller family. It is well documented that this family prefers to work behind the scenes, and they have also expressed a strong belief in population control. David Icke in his book entitled, "... and the truth shall set you free", wrote:

 

'In 1952, after decades of funding and supporting eugenics, John D. Rockefeller III established his Population Council, which still exists today. This Elite front has been calling for zero population growth in the United States and, in the words of its 1979 annual report: ... "the spread of the zero population movement... in the developed countries." '

In the population control agenda there does seem to be a particular interest in reducing the population of those of what is considered "lesser stock" (see http://www.thinktwice.com/birthcon.htm), yet all sections of the community are encouraged to receive the vaccine, but do you know which schools and localities are getting which batches of vaccine? Something to think about.

By the way, as all other vaccines, no proper placebo-controlled studies have been done with this vaccine. The so-called placebo group receives an injection of aluminium hydroxyphosphate "and everything else present in the adjuvant", according to the contact researcher for the major trials. Why don't they receive an inactive substance, which is what a placebo is defined to be? Apparently because, in the understanding of this researcher, "In vaccine trials,... (it) is usual, good clinical practice, to give adjuvant to the placebo arm." So what are these researchers (manufacturer-funded, of course) so afraid of, that they will not give a proper placebo to the placebo group?

Back to Top